The significant variation in age across subtypes provides some explanation, as age at presentation of HCC has been linked to genetic variations, such as UGT2B28, suggesting that the genes identified in this study may serve as potential biomarkers for predicting the age of onset in HCC patients [45]. The gene discussed is UGT2B28; the disease is hepatocellular carcinoma.